RadNet, Inc.

RDNT 10-Q · Q1 2026

RDNT Q1 2026 request

Playground key active
Request URL /api/financials?ticker=RDNT&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 575,631 471,399 +22.1%
Show Product Lines breakouts
Commercial insurance 315,869 262,488 +20.3%
Health Care Other 24,804 12,543 +97.8%
Health Care Patient Service 545,218 439,349 +24.1%
Management fee revenue 7,481 6,279 +19.1%
Medicaid 13,991 11,690 +19.7%
Medicare 137,179 108,199 +26.8%
Other payors 33,590 27,691 +21.3%
Revenue under capitation arrangements 30,413 32,050 -5.1%
Workers' compensation/personal injury 12,304 10,459 +17.6%
Show Business Segments breakouts
Digital health 18,816 10,021 +87.8%
Digital health · Intersegment Elimination -10,305 -9,200 -12.0%
Digital health · Operating Segments 29,121 19,221 +51.5%
Imaging Center 556,815 461,378 +20.7%
Imaging Center · Operating Segments 556,815 461,378 +20.7%
Show Consolidation Items breakouts
Intersegment Elimination -10,305 -9,200 -12.0%
Operating Segments 585,936 480,599 +21.9%
Operating Expenses Excluding Depreciation And Amortization 550,512 453,480 +21.4%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 60,140 54,976 +9.4%
Depreciation & Amortization 44,967 35,483 +26.7%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 4,994 5,176 -3.5%
Gain Loss On Disposition Of Assets 2,591 402 +544.5%
Severance Costs1 1,464 747 +96.0%
Operating Expenses 599,534 495,500 +21.0%
Operating Income -23,903 -24,101 +0.8%
Show Business Segments breakouts
Digital health · Operating Segments -11,141 -3,117 -257.4%
Imaging Center · Operating Segments 36,260 15,648 +131.7%
Show Consolidation Items breakouts
Operating Segments 25,119 12,531 +100.5%
Interest Expense Debt 17,657 17,239 +2.4%
Income Loss From Equity Method Investments -3,825 -2,599 -47.2%
Other Non-Operating Income (Expense) -4,907 -7,712 +36.4%
Non-Operating Income (Expense) 8,925 9,034 -1.2%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 65 494 -86.8%
Income Before Taxes -32,828 -33,135 +0.9%
Income Tax Expense (Benefit) 8,096 3,398 +138.3%
Net Income -24,732 -29,737 +16.8%
Show Equity Components breakouts
Noncontrolling Interest 8,734 8,189 +6.7%
Parent -33,466 -37,926 +11.8%
Retained Earnings -33,466 -37,926 +11.8%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 8,131 5,628 +44.5%
Net Income Loss Attributable To Noncontrolling Interest 8,734 8,189 +6.7%
Net Income -33,466 -37,926 +11.8%
EPS (Basic) -0.43 -0.51 +15.7%
EPS (Diluted) -0.43 -0.51 +15.7%
Wtd Avg Shares (Basic) 77,057,835 74,382,356 +3.6%
Wtd Avg Shares (Diluted) 77,057,835 74,382,356 +3.6%
Revenue (Q)
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 73,330 66,274 +10.6%
Interest Income 5 7.7 -35.1%
Comprehensive Income -40,817 -32,784 -24.5%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 455,339 717,323 -36.5%
Accounts Receivable 209,090 200,127 +4.5%
Other Receivables Net Current (Q)
Show Related Party Transactions By Related Party breakouts
Affiliated Entity 11,033 34,885 -68.4%
Prepaid Expenses & Other Current Assets 65,313 63,526 +2.8%
Total Current Assets 740,775 1,015,861 -27.1%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 85,217 66,970 +27.2%
Non-Current Assets
Property, Plant & Equipment 862,057
Operating Lease Right-of-Use Assets 760,975 665,754 +14.3%
Goodwill 1,094,699
Show Business Segments breakouts
Digital Health segment 336,051
Imaging Center 758,648
Show Business Acquisition breakouts
Business Acquisitions 17,159
Total Assets 3,885,389 3,336,264 +16.5%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 161 117.5 +37.0%
Intangible Assets (Q)
Show Finite Lived Intangible Assets By Major Class breakouts
Certifications 2,786
Covenant not to compete and other contracts 6,435 2,193 +193.4%
Customer Relationships 132,649 14,102 +840.6%
Developed Technology & Software 66,353 33,680 +97.0%
Management service contracts 12,961 15,249 -15.0%
Others 2,080
Patent and trademarks 1,377 1,531 -10.1%
Trade Names 10,460 301 +3375.1%
Other Assets
Property Plant And Equipment Net Including Right Of Use Assets 1,623,032 1,374,002 +18.1%
Other Intangible Assets Net 253,481 79,736 +217.9%
Deferred Finance Costs Noncurrent Net 1,538 2,120 -27.5%
Investments In Affiliates Subsidiaries Associates And Joint Ventures 131,409 110,803 +18.6%
Deposits Assets 40,455 36,262 +11.6%
Current Liabilities
Accounts Payable And Accrued Liabilities Current 454,602
Other Liabilities Current (Q)
Show Related Party Transactions By Related Party breakouts
Affiliated Entity 75,960 51,410 +47.8%
Deferred Revenue (Current) 11,975 3,416 +250.6%
Operating Lease Liability Current 66,591 57,896 +15.0%
Notes Payable Current 26,506 24,677 +7.4%
Total Current Liabilities 635,634 505,399 +25.8%
Show Equity Method Investment Nonconsolidated Investee breakouts
Equity Method Investment Nonconsolidated Investee Or Group Of Investees 12,271 45,309 -72.9%
Current Portion of Long-Term Debt 26,506
Show Long-Term Debt Type breakouts
Commercial Paper 8.6
Non-Current Liabilities
Finance Lease Liability Noncurrent 4,016
Operating Lease Liabilities 777,268 678,029 +14.6%
Long Term Notes Payable 1,059,977 985,454 +7.6%
Deferred Tax Liabilities 34,150 27,555 +23.9%
Other Non-Current Liabilities 21,632 3,310 +553.5%
Total Liabilities 2,532,677 2,199,747 +15.1%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 41.4 31.5 +31.4%
Long-Term Debt 1,086,483 1,010,131 +7.6%
Show Debt Instrument breakouts
Equipment notes payable at 3.6% to 7.2%, due through 2029, collateralized by medical equipment 15,626 22,578 -30.8%
First Lien Term Loan · Secured Debt 958,680
Restated Agreement [Member] · Secured Debt 120,937
Long-Term Debt 1,059,977 985,454 +7.6%
Stockholders' Equity
Common Stock 8 7 +14.3%
Additional Paid-In Capital 1,211,912 1,016,762 +19.2%
Accumulated Other Comprehensive Income -2,466 -3,919 +37.1%
Retained Earnings -128,903 -114,711 -12.4%
Total Stockholders' Equity 1,080,551
Minority Interest 272,161 238,378 +14.2%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1,352,712 1,136,517 +19.0%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -2,466 -3,919 +37.1%
Additional Paid In Capital 1,211,912 1,016,762 +19.2%
Common Stock 8 7 +14.3%
Noncontrolling Interest 272,161 238,378 +14.2%
Parent 1,080,551 898,139 +20.3%
Retained Earnings -128,903 -114,711 -12.4%
Total Liabilities & Equity 3,885,389 3,336,264 +16.5%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Operating Lease Right Of Use Asset Amortization Expense 16,298 14,431 +12.9%
Income Loss From Equity Method Investments Net Of Distributions -1,069 -2,599 +58.9%
Amortization of Financing Costs 779 728 +7.0%
Stock-Based Compensation 31,375 28,494 +10.1%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 -2,764
Show Business Acquisition breakouts
CIMAR UK Limited 937
Kolb Radiology P.C. 200
See-Mode Technologies Pte. Ltd. 1,627
Change in Accounts Receivable 9,375 -14,306 +165.5%
Increase Decrease In Other Current Assets -6,172 -7,206 +14.3%
Increase Decrease In Other Noncurrent Assets -660 -1,691 +61.0%
Increase Decrease In Deferred Income Taxes -9,099 5,137 -277.1%
Increase Decrease In Operating Lease Liability -13,299 -21,968 +39.5%
Increase Decrease In Deferred Revenue 234 128 +82.8%
Increase Decrease In Accounts Payable And Accrued Liabilities 31,148 25,658 +21.4%
Net Cash from Operations 78,972 41,481 +90.4%
Investing Activities
Payments To Acquire Buildings -304,151 -3,794 -7916.6%
Payments To Acquire Other Property Plant And Equipment -69,932 -48,833 -43.2%
Proceeds From Sale Of Property Plant And Equipment 277 23 +1104.3%
Proceeds From Collection Of Notes Receivable 2,833
Net Cash from Investing -370,973 -56,751 -553.7%
Financing Activities
Principal Repayments On Notes And Leases Payable -9,953 -1,718 -479.3%
Repayments Of Secured Debt -5,252 -5,000 -5.0%
Payments To Minority Shareholders -2,402 -913 -163.1%
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options 103 121 -14.9%
Net Cash from Financing -17,504 -7,510 -133.1%
Supplemental
Interest Paid 17,073 18,010 -5.2%
Income Taxes Paid 519 272 +90.8%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -2,371 83 -2956.6%
Net Change in Cash -311,876 -22,697 -1274.1%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 455,339 717,323 -36.5%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key